| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 22, 2024 |
| Accession Number: | 0001104659-24-035563 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 22, 2024 |
| Accession Number: | 0001104659-24-035563 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/29/2023 | $157.00 | Buy → Hold | Truist |
| 8/9/2023 | $125.00 | Overweight | CapitalOne |
| 4/19/2023 | Outperform | William Blair | |
| 2/6/2023 | $130.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 1/17/2023 | Buy → Neutral | Guggenheim | |
| 12/15/2022 | $86.00 | Neutral | Wedbush |
| 11/7/2022 | $90.00 | Outperform | Wolfe Research |
| 10/19/2022 | $130.00 | Outperform | Robert W. Baird |